The FDA policy change may speed up approval for hairloss drugs like PP405, VDPHL-01, and Breezula by potentially eliminating the need for a second confirmatory Phase 3 trial. Approval timelines could be as early as 2028 for some treatments if Phase 3 results are strong.
A 22-year-old man shared his experience with hairloss, which began at age 20, and his treatment with finasteride and oral minoxidil, planning to add microneedling. Since experiencing hairloss, he has changed his perspective and now notices other men's hairloss more, viewing them positively, and others in the conversation relate to this shift in perception.
Microneedling should target depths of 0.5mm to 1.5mm for hairloss, with weekly sessions at 1mm recommended. Combining microneedling with Minoxidil is common for improved results.
The user experienced worsening hairloss despite using dutasteride tablets and is considering switching to dutasteride gel capsules due to concerns about tablet bioavailability. Another user mentioned that countries like Japan, Korea, and India use the tablet form, suggesting the form may not be the issue.
The conversation humorously discusses using a full head wig for hair, beard, and perfect skin, with mentions of treatments like finasteride, RU58841, and microneedling. It highlights a shift from serious hairloss discussions to satire and memes.